Relypsa Inc (RLYP) financial statements (2022 and earlier)

Company profile

Business Address 100 CARDINAL WAY
REDWOOD CITY, CA 94063
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments240,716135,757
Cash and cash equivalents63,72330,264
Short-term investments176,993105,493
Restricted cash and investments 268
Receivables1,309425
Inventory, net of allowances, customer advances and progress billings8,851 
Inventory8,851 
Other undisclosed current assets5,4052,756
Total current assets:256,281139,206
Noncurrent Assets
Property, plant and equipment9,6273,467
Restricted cash and investments1,436686
Other noncurrent assets10,9848,480
Total noncurrent assets:22,04712,633
TOTAL ASSETS:278,328151,839
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities52,60915,327
Accounts payable3,0373,156
Accrued liabilities37,7377,778
Employee-related liabilities11,8354,393
Debt301432
Deferred revenue and credits16,2691,156
Total current liabilities:69,17916,915
Noncurrent Liabilities
Long-term debt and lease obligation15,59215,213
Long-term debt, excluding current maturities15,59215,213
Liabilities, other than long-term debt8,6846,583
Deferred revenue and credits8,684983
Liability for uncertainty in income taxes 5,600
Other undisclosed noncurrent liabilities (5,333)
Total noncurrent liabilities:24,27616,463
Total liabilities:93,45533,378
Stockholders' equity
Stockholders' equity attributable to parent184,873118,461
Common stock4235
Additional paid in capital669,331424,175
Accumulated other comprehensive loss(56)(21)
Accumulated deficit(484,444)(305,728)
Total stockholders' equity:184,873118,461
TOTAL LIABILITIES AND EQUITY:278,328151,839

Income statement (P&L) ($ in thousands)

12/31/2015
12/31/2014
Operating expenses(196,436)(78,141)
Other undisclosed operating income18,550 
Operating loss:(177,886)(78,141)
Nonoperating income915149
Investment income, nonoperating(1,314) 
Interest and debt expense(1,745)(1,896)
Net loss available to common stockholders, diluted:(178,716)(79,888)

Comprehensive Income ($ in thousands)

12/31/2015
12/31/2014
Net loss:(178,716)(79,888)
Comprehensive loss:(178,716)(79,888)
Other undisclosed comprehensive loss, net of tax, attributable to parent(35)(21)
Comprehensive loss, net of tax, attributable to parent:(178,751)(79,909)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: